{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T02:29:03Z","timestamp":1771036143879,"version":"3.50.1"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T00:00:00Z","timestamp":1466035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156999","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T19:00:46Z","timestamp":1466103646000},"page":"e0156999","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mucolytic Effectiveness of Tyloxapol in Chronic Obstructive Pulmonary Disease - A Double-Blind, Randomized Controlled Trial"],"prefix":"10.1371","volume":"11","author":[{"given":"Martin","family":"Koppitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Eschenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Salzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Rosewich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Zielen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,6,16]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/thx.2005.046227","article-title":"Convergence of the epidemiology and pathology of COPD","volume":"61","author":"J Vestbo","year":"2006","journal-title":"Thorax"},{"issue":"6077","key":"ref2","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1136\/bmj.1.6077.1645","article-title":"The natural history of chronic airflow obstruction","volume":"1","author":"C Fletcher","year":"1977","journal-title":"British medical journal"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1164\/ajrccm.153.5.8630597","article-title":"Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group","volume":"153","author":"J Vestbo","year":"1996","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/rccm.200603-381OC","article-title":"Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm","volume":"175","author":"R de Marco","year":"2007","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"7009","key":"ref5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(57)91637-9","article-title":"An evaluation of sputum examination in chronic bronchitis","volume":"273","author":"W BRUMFITT","year":"1957","journal-title":"Lancet (London, England)"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.200901-0047OC","article-title":"The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort","volume":"180","author":"R Kohansal","year":"2009","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"116","key":"ref7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1183\/09059180.00003610","article-title":"Mucoactive therapy in COPD","volume":"19","author":"M Decramer","year":"2010","journal-title":"European respiratory review: an official journal of the European Respiratory Society"},{"issue":"116","key":"ref8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/09059180.00003510","article-title":"Mucoactive drugs","volume":"19","author":"R Balsamo","year":"2010","journal-title":"European respiratory review: an official journal of the European Respiratory Society"},{"key":"ref9","first-page":"CD001287","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","volume":"7","author":"P Poole","year":"2015","journal-title":"The Cochrane database of systematic reviews"},{"key":"ref10","unstructured":"Marc Decramer MD. Global Strategy for Diagnosis, Management, and Prevention of COPD (Updated 2015) [cited 2015 Aug 21]. Available from: URL:<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.goldcopd.org\/guidelines-global-strategy-for-diagnosis-management.html\" xlink:type=\"simple\">http:\/\/www.goldcopd.org\/guidelines-global-strategy-for-diagnosis-management.html<\/ext-link>."},{"issue":"6","key":"ref11","first-page":"252","article-title":"Die Bedeutung moderner Netzmittel f\u00fcr die Chirurgie","volume":"29","author":"K HUTSCHENREUTER","year":"1958","journal-title":"Der Chirurg; Zeitschrift f\u00fcr alle Gebiete der operativen Medizen"},{"key":"ref12","first-page":"2296","article-title":"Tacholiquin in the pre- and postoperative phase of thoracic surgical interventions","volume":"104","author":"FM WAGENEDER","year":"1962","journal-title":"M\u00fcnchener medizinische Wochenschrift (1950)"},{"issue":"7206","key":"ref13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0140-6736(61)91090-X","article-title":"A new mucolytic agent by aerosol for inhalation in chronic bronchitis","volume":"2","author":"KN PALMER","year":"1961","journal-title":"Lancet (London, England)"},{"issue":"9","key":"ref14","first-page":"707","article-title":"New technique of humidification in pediatrics","volume":"151","author":"SF RAVENEL","year":"1953","journal-title":"Journal of the American Medical Association"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jama.1954.02940440027008","article-title":"Diagnosis and treatment of encrustations in the trachea: their relation to radical surgery of the head and neck","volume":"154","author":"JJ CONLEY","year":"1954","journal-title":"Journal of the American Medical Association"},{"issue":"18","key":"ref16","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1056\/NEJM195511032531804","article-title":"Alevaire as a mycolytic agent","volume":"253","author":"ML TAINTER","year":"1955","journal-title":"The New England journal of medicine"},{"issue":"4","key":"ref17","article-title":"Surface Active Agents in Sputum Evacuation: A Blind Comparison with Normal Saline Solution and Distilled Water","volume":"60","author":"PN Paez","year":"1971","journal-title":"Chest"},{"key":"ref18","unstructured":"Wilde A. Oberfl\u00e4chenspannungs- und Viskosit\u00e4ts-Messungen an Sputa unter dem Einfluss von Tacholiquin. Notabene Medici 1978; (8. Heft 1.)."},{"issue":"2","key":"ref19","first-page":"102","article-title":"Planned care for patients with bronchiectasis","volume":"82","author":"SM FARBER","year":"1955","journal-title":"California medicine"},{"issue":"3 Pt 1","key":"ref20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/ajrccm.154.3.8810619","article-title":"Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCI, and reduces viscosity of cystic fibrosis sputum","volume":"154","author":"AJ Ghio","year":"1996","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"7","key":"ref21","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.rmed.2011.02.006","article-title":"Body plethysmography\u2014its principles and clinical use","volume":"105","author":"CP Cri\u00e9e","year":"2011","journal-title":"Respiratory Medicine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1465-9921-13-78","article-title":"Airway responses and inflammation in subjects with asthma after four days of repeated high-single-dose allergen challenge","volume":"13","author":"J Schulze","year":"2012","journal-title":"Respiratory research"},{"issue":"8","key":"ref23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/thorax.57.8.667","article-title":"Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis","volume":"57","author":"IS Woolhouse","year":"2002","journal-title":"Thorax"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cyto.2014.10.026","article-title":"Airway inflammation in children and adolescents with bronchiolitis obliterans","volume":"73","author":"M Rosewich","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1203\/01.PDR.0000182598.98167.24","article-title":"Lipopolysaccharide binding protein, cytokine production in whole blood, and lipoproteins in cystic fibrosis","volume":"58","author":"S Schmitt-Groh\u00e9","year":"2005","journal-title":"Pediatric research"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2010.02.004","article-title":"Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function","volume":"50","author":"O Eickmeier","year":"2010","journal-title":"Cytokine"},{"issue":"12","key":"ref27","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"F Kellett","year":"2011","journal-title":"Respiratory Medicine"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/oemed-2013-101654","article-title":"Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH","volume":"71","author":"AE Dijkstra","year":"2014","journal-title":"Occupational and environmental medicine"},{"issue":"116","key":"ref29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09059180.00002710","article-title":"Revisited role for mucus hypersecretion in the pathogenesis of COPD","volume":"19","author":"I Cerveri","year":"2010","journal-title":"European respiratory review: an official journal of the European Respiratory Society"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000196540","article-title":"Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial","volume":"63","author":"L Allegra","year":"1996","journal-title":"Respiration; international review of thoracic diseases"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.92.4.618","article-title":"A controlled trial of ambroxol in chronic bronchitis","volume":"92","author":"GH Guyatt","year":"1987","journal-title":"Chest"},{"issue":"1","key":"ref32","first-page":"75","article-title":"The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis","volume":"97","author":"TL Petty","year":"1990","journal-title":"Chest"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"BR Celli","year":"2004","journal-title":"The European respiratory journal"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.rmed.2004.05.006","article-title":"Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis","volume":"99","author":"F Kellett","year":"2005","journal-title":"Respiratory Medicine"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1378\/chest.12-1763","article-title":"Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis","volume":"144","author":"D Bilton","year":"2013","journal-title":"Chest"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0954-6111(06)80220-9","article-title":"N-acetylcysteine by metered dose inhaler in the treatment of chronic bronchitis: a multi-centre study","volume":"86","author":"M Dueholm","year":"1992","journal-title":"Respiratory Medicine"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/thx.51.4.429","article-title":"Evaluation of nebulised acetylcysteine and normal saline in the treatment of sputum retention following thoracotomy","volume":"51","author":"AM Gallon","year":"1996","journal-title":"Thorax"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.4187\/respcare.04086","article-title":"Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review","volume":"60","author":"NA Sathe","year":"2015","journal-title":"Respiratory care"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"e97491","DOI":"10.1371\/journal.pone.0097491","article-title":"Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: evidence of a gender effect","volume":"9","author":"R Faner","year":"2014","journal-title":"PloS one"},{"issue":"26","key":"ref40","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"JC Hogg","year":"2004","journal-title":"The New England journal of medicine"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"SH Donaldson","year":"2006","journal-title":"The New England journal of medicine"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/thx.52.10.900","article-title":"Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis","volume":"52","author":"M Robinson","year":"1997","journal-title":"Thorax"},{"issue":"7297","key":"ref43","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/bmj.322.7297.1271","article-title":"Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review","volume":"322","author":"PJ Poole","year":"2001","journal-title":"BMJ (Clinical research ed.)"},{"issue":"9470","key":"ref44","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial","volume":"365","author":"M Decramer","year":"2005","journal-title":"The Lancet"},{"issue":"7\u20138","key":"ref45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00508-014-0692-4","article-title":"N-acetylcysteine in patients with COPD exacerbations associated with increased sputum","volume":"127","author":"Z Ayfer Aytemur","year":"2015","journal-title":"Wiener klinische Wochenschrift"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1440-1843.2005.00659.x","article-title":"Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: effect on lung function, health status and sputum","volume":"10","author":"E Daviskas","year":"2005","journal-title":"Respirology (Carlton, Vic.)"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1034\/j.1399-3003.1999.14c30.x","article-title":"The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study","volume":"14","author":"M Robinson","year":"1999","journal-title":"The European respiratory journal"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/thx.51.2.119","article-title":"In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis","volume":"51","author":"PL Shah","year":"1996","journal-title":"Thorax"},{"issue":"4","key":"ref49","first-page":"889","article-title":"Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease","volume":"110","author":"K McCoy","year":"1996","journal-title":"Pulmozyme Study Group. Chest"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"AE O'Donnell","year":"1998","journal-title":"Chest"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis","volume":"106","author":"CHH Nicolson","year":"2012","journal-title":"Respiratory Medicine"},{"issue":"1","key":"ref52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1378\/chest.12-2357","article-title":"High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study","volume":"144","author":"HN Tse","year":"2013","journal-title":"Chest"},{"issue":"1","key":"ref53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thx.43.1.57","article-title":"Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy","volume":"43","author":"PP Sutton","year":"1988","journal-title":"Thorax"},{"issue":"3","key":"ref54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1445-5994.1998.tb01956.x","article-title":"The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD)","volume":"28","author":"PJ Poole","year":"1998","journal-title":"Australian and New Zealand journal of medicine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2466-4-9","article-title":"Is nebulized saline a placebo in COPD?","volume":"4","author":"SY Khan","year":"2004","journal-title":"BMC pulmonary medicine"},{"issue":"9","key":"ref56","first-page":"715","article-title":"Langzeittherapie \u00fcber 2 Jahre mit Ambroxol (Mucosolvan) Retardkapseln bei Patienten mit chronischer Bronchitis. Ergebnisse einer Doppelblindstudie an 180 Patienten","volume":"42","author":"UH Cegla","year":"1988","journal-title":"Praxis und Klinik der Pneumologie"},{"issue":"Suppl 1","key":"ref57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000195274","article-title":"Ambroxol for the prevention of chronic bronchitis exacerbations: long-term multicenter trial. Protective effect of ambroxol against winter semester exacerbations: a double-blind study versus placebo","volume":"51","author":"D Olivieri","year":"1987","journal-title":"Respiration; international review of thoracic diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T20:59:03Z","timestamp":1568062743000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156999"}},"subtitle":[],"editor":[{"given":"Hong-Long (James)","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,16]]},"references-count":57,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156999","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,16]]}}}